Mexican Rx Counterfeits Should Be Focus Of Public Education - Testimony
Executive Summary
A public education effort should highlight the threat of counterfeit drugs imported from Mexico, University of Texas Center for Pharmacoeconomics Director Marv Shepherd, PhD, suggested to the House Commerce/Oversight Subcommittee.
You may also be interested in...
Pharmacies Should Have Same Right To Import As Manufacturers - NCPA
Licensed pharmacists should have the same right to import and re-import prescription drugs as manufacturers, the National Community Pharmacists Association maintained in an Aug. 24 letter to the House and Senate conferees on the Agriculture Appropriations bill (HR 4461).
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials